vs
Side-by-side financial comparison of Entrada Therapeutics, Inc. (TRDA) and Waterstone Financial, Inc. (WSBF). Click either name above to swap in a different company.
Waterstone Financial, Inc. is the larger business by last-quarter revenue ($37.2M vs $20.6M, roughly 1.8× Entrada Therapeutics, Inc.). On growth, Waterstone Financial, Inc. posted the faster year-over-year revenue change (16.7% vs -65.2%). Waterstone Financial, Inc. produced more free cash flow last quarter ($23.0M vs $-39.7M). Over the past eight quarters, Waterstone Financial, Inc.'s revenue compounded faster (7.1% CAGR vs 6.4%).
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
Waterstone Financial, Inc. is a U.S. bank holding company headquartered in Wisconsin. It offers retail and commercial banking services, residential mortgages, and wealth management solutions, primarily serving consumers and small to medium-sized businesses across the U.S. Midwest region.
TRDA vs WSBF — Head-to-Head
Income Statement — Q1 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.6M | $37.2M |
| Net Profit | $-17.3M | — |
| Gross Margin | — | — |
| Operating Margin | -106.0% | 27.0% |
| Net Margin | -84.4% | — |
| Revenue YoY | -65.2% | 16.7% |
| Net Profit YoY | -173.8% | — |
| EPS (diluted) | $-0.42 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $37.2M | ||
| Q3 25 | — | $37.0M | ||
| Q2 25 | — | $38.0M | ||
| Q1 25 | $20.6M | $29.7M | ||
| Q4 24 | $37.4M | $31.8M | ||
| Q3 24 | $19.6M | $34.1M | ||
| Q2 24 | $94.7M | $37.2M | ||
| Q1 24 | $59.1M | $32.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | $7.9M | ||
| Q2 25 | — | $7.7M | ||
| Q1 25 | $-17.3M | $3.0M | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $-14.0M | $4.7M | ||
| Q2 24 | $55.0M | $5.7M | ||
| Q1 24 | $23.5M | $3.0M |
| Q4 25 | — | 27.0% | ||
| Q3 25 | — | 26.6% | ||
| Q2 25 | — | 25.4% | ||
| Q1 25 | -106.0% | 13.1% | ||
| Q4 24 | -15.7% | 19.5% | ||
| Q3 24 | -110.7% | 17.3% | ||
| Q2 24 | 56.4% | 19.2% | ||
| Q1 24 | 35.7% | 14.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | 21.4% | ||
| Q2 25 | — | 20.3% | ||
| Q1 25 | -84.4% | 10.2% | ||
| Q4 24 | 3.0% | — | ||
| Q3 24 | -71.7% | 13.9% | ||
| Q2 24 | 58.1% | 15.4% | ||
| Q1 24 | 39.7% | 9.4% |
| Q4 25 | — | $0.43 | ||
| Q3 25 | — | $0.45 | ||
| Q2 25 | — | $0.43 | ||
| Q1 25 | $-0.42 | $0.17 | ||
| Q4 24 | $-0.20 | $0.28 | ||
| Q3 24 | $-0.35 | $0.26 | ||
| Q2 24 | $1.55 | $0.31 | ||
| Q1 24 | $0.68 | $0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $67.8M | — |
| Total DebtLower is stronger | — | $412.3M |
| Stockholders' EquityBook value | $417.3M | $349.4M |
| Total Assets | $486.5M | $2.3B |
| Debt / EquityLower = less leverage | — | 1.18× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $67.8M | — | ||
| Q4 24 | $101.2M | — | ||
| Q3 24 | $78.0M | — | ||
| Q2 24 | $185.3M | — | ||
| Q1 24 | $68.4M | — |
| Q4 25 | — | $412.3M | ||
| Q3 25 | — | $469.1M | ||
| Q2 25 | — | $465.7M | ||
| Q1 25 | — | $395.9M | ||
| Q4 24 | — | $446.5M | ||
| Q3 24 | — | $560.1M | ||
| Q2 24 | — | $660.8M | ||
| Q1 24 | — | $634.2M |
| Q4 25 | — | $349.4M | ||
| Q3 25 | — | $345.5M | ||
| Q2 25 | — | $341.5M | ||
| Q1 25 | $417.3M | $341.4M | ||
| Q4 24 | $428.7M | $339.1M | ||
| Q3 24 | $422.4M | $342.0M | ||
| Q2 24 | $429.9M | $334.9M | ||
| Q1 24 | $269.4M | $338.0M |
| Q4 25 | — | $2.3B | ||
| Q3 25 | — | $2.3B | ||
| Q2 25 | — | $2.3B | ||
| Q1 25 | $486.5M | $2.2B | ||
| Q4 24 | $526.3M | $2.2B | ||
| Q3 24 | $554.6M | $2.2B | ||
| Q2 24 | $582.0M | $2.3B | ||
| Q1 24 | $510.8M | $2.2B |
| Q4 25 | — | 1.18× | ||
| Q3 25 | — | 1.36× | ||
| Q2 25 | — | 1.36× | ||
| Q1 25 | — | 1.16× | ||
| Q4 24 | — | 1.32× | ||
| Q3 24 | — | 1.64× | ||
| Q2 24 | — | 1.97× | ||
| Q1 24 | — | 1.88× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-38.5M | $24.2M |
| Free Cash FlowOCF − Capex | $-39.7M | $23.0M |
| FCF MarginFCF / Revenue | -192.9% | 61.9% |
| Capex IntensityCapex / Revenue | 5.6% | 3.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-58.0M | $43.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $24.2M | ||
| Q3 25 | — | $32.7M | ||
| Q2 25 | — | $-38.4M | ||
| Q1 25 | $-38.5M | $26.7M | ||
| Q4 24 | $-31.6M | $48.1M | ||
| Q3 24 | $-24.3M | $74.1M | ||
| Q2 24 | $39.8M | $-39.5M | ||
| Q1 24 | $-25.5M | $-9.9M |
| Q4 25 | — | $23.0M | ||
| Q3 25 | — | $32.4M | ||
| Q2 25 | — | $-38.5M | ||
| Q1 25 | $-39.7M | $26.5M | ||
| Q4 24 | $-32.2M | $47.0M | ||
| Q3 24 | $-24.9M | $73.9M | ||
| Q2 24 | $38.8M | $-39.7M | ||
| Q1 24 | $-26.4M | $-10.3M |
| Q4 25 | — | 61.9% | ||
| Q3 25 | — | 87.5% | ||
| Q2 25 | — | -101.2% | ||
| Q1 25 | -192.9% | 89.2% | ||
| Q4 24 | -86.2% | 147.5% | ||
| Q3 24 | -127.3% | 216.9% | ||
| Q2 24 | 41.0% | -106.7% | ||
| Q1 24 | -44.6% | -31.9% |
| Q4 25 | — | 3.1% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | 5.6% | 0.9% | ||
| Q4 24 | 1.7% | 3.5% | ||
| Q3 24 | 3.3% | 0.6% | ||
| Q2 24 | 1.1% | 0.4% | ||
| Q1 24 | 1.4% | 1.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | 4.13× | ||
| Q2 25 | — | -4.98× | ||
| Q1 25 | — | 8.81× | ||
| Q4 24 | -27.94× | — | ||
| Q3 24 | — | 15.67× | ||
| Q2 24 | 0.72× | -6.92× | ||
| Q1 24 | -1.09× | -3.27× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
